On July 13, Cigna Group rose 3.11% in regular trading, trading at approximately $301.79 per share, with turnover of $54.78 million.

On the news front, Bernstein recently raised its price target on Cigna from $371 to $381, maintaining an Outperform rating. This marks the third consecutive upward revision by the firm, which upgraded the stock to Outperform in March with a $358 target. Morgan Stanley has also highlighted that managed-care companies including Cigna could benefit from improving medical utilization trends and potential AI-driven operational efficiency gains across healthcare systems.

Fundamentally, Cigna reported Q1 adjusted EPS of $7.79, beating the consensus estimate of $7.61 by 2.37%, while revenue of $68.52 billion also exceeded expectations. Management raised full-year adjusted EPS guidance to at least $30.35, signaling confidence in sustained earnings momentum. The company also plans to exit individual exchange business by year-end, refocusing on core operations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)